| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| QNBC | QNB CORP | N/A | 0.87% | 0.00% | $0.3900 | $0.39 | 17% | 0 | ||
| BRAI | BRAIIN LTD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| XTER | KARMAN LINE ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| IPHXU | INFLECTION POINT ACQUISITION CORP VIII | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| JTTT | JATT III ACQUISITION CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| AUXX | GOLD X2 MINING INC | N/A | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NSAI | NORTHSTRIVE ACQUISITION CORP I | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| BLSM | BLOSSOMHILL THERAPEUTICS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| LYNX | LYNTRIS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| ADBT | ADVASA HOLDINGS INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| PLCI | PELICAN ACQUISITION II CORP | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| BREZ | BREEZE ACQUISITION CORP II | N/A | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REAX | REAL REMAX GROUP INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.